About: Immunome, Inc., a biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics in the United States. The company develops clinical asset comprising Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial. It is also developing preclinical assets, including IM-3050, a fibroblast activation protein targeted radioligand therapy; and solid tumor ADC drug candidates, such as IM-1617, IM-1340, and IM-1335. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.
Sector: Healthcare
Industry: Biotechnology
Latest price: $20.78 (+2.31%)
IMNM NASDAQ Immunome Inc
Immunome Inc share price
IMNM price activity
Last Price
$20.780
Change (24hr)
0.47 USD (2.31%)
Volume
16.23K
Volume (4w avg)
-
Previous Close
$20.31
Last Trade
04 Nov, 2:27 pm GMT+0
Delayed
04 Nov, 2:27 pm GMT+0
IMNM price performance
Delayed
04 Nov, 2:27 pm GMT+0
IMNM details
IMNM Market Signals